# Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-efficacy-of-artemisinin-piperaquine-for-treatment-of-covid-19-an-open/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Guoming Li,Mei Yuan,Haihong Li,Changsheng Deng,Qi Wang,Yexiao Tang,Hongying Zhang,Weisheng Yu,Qin Xu,Yuanyuan Zou,Yueming Yuan,Jia–Wen Guo,Jin Chun-ming,Xiangdong Guan,Fengjie Xie,Jianping Song |
| Citations | 62 |
| DOI | 10.1016/j.ijantimicag.2020.106216 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.sciencedirect.com/science/article/pii/S0924857920304271/pdf |
| OpenAlex ID | https://openalex.org/W3094725404 |
| PMID | 33152450 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yueming Yuan](https://scholariq.org/researchers/yueming-yuan/)
- [Changsheng Deng](https://scholariq.org/researchers/changsheng-deng/)

## Paper journal

- [International Journal of Antimicrobial Agents](https://scholariq.org/journals/international-journal-of-antimicrobial-agents/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.